Bridgeway Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Bridgeway Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $4.3 Million - $5.6 Million	-20,850 Reduced 73.81%	7,400 $1.53 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $3.11 Million - $4.18 Million	-15,300 Reduced 35.13%	28,250 $7.65 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $287,910 - $417,970	-1,750 Reduced 3.86%	43,550 $10.3 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $1.57 Million - $1.76 Million	-8,075 Reduced 15.13%	45,300 $8.88 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $734,840 - $841,000	-4,000 Reduced 6.97%	53,375 $11.2 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $1.32 Million - $1.79 Million	-6,900 Reduced 10.74%	57,375 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $576,546 - $731,454	2,925 Added 4.77%	64,275 $14 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $4.52 Million - $6.2 Million	-24,750 Reduced 28.75%	61,350 $12.1 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $17.6 Million - $26 Million	86,100 New	86,100 $18.4 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.